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ABSTRACT
Preterm birth interrupts the normal development of the 
respiratory system. Taken together with the lung injury that 
can occur antenatally such as from chorioamnionitis or 
postnatally by interventions such as mechanical ventilation 
and oxygen therapy, survivors are at risk of developing 
long term deficits of their respiratory system. Decrements 
of lung spirometry have been regularly reported in those 
born preterm across all gestational ages. Those who 
develop chronic lung disease of prematurity (also called 
bronchopulmonary dysplasia) are the most affected, but 
lung function decrements are also seen in those born at 
later gestation of between 33 and 36 weeks, a population 
that generally does not require respiratory support in the 
neonatal period. Besides spirometry, many other techniques 
have been used to assess the status of the respiratory 
system including measurement of static lung volumes, 
airway resistance and compliance, bronchial hyper-
responsiveness, diffusing capacity, exhaled nitric oxide 
and newer imaging techniques including hyperpolarised 
3-helium magnetic resonance imaging. Discussed in this 
review are the findings from such methods to delineate the 
respiratory outcomes that occur after preterm birth.
Key words: Preterm birth, lung physiology, broncho 
pulmonary dysplasia, chronic lung disease of 
prematurity, static lung volumes, imaging, multiple 
breath washout.
RESUMEN 
El nacimiento prematuro interrumpe el desarrollo normal 
del aparato respiratorio. Los sobrevivientes tienen riesgo 
de desarrollar déficit en su función, debido a la injuria 
prenatal por corioamnionitis y postnatal por ventilación 
mecánica y oxigenoterapia. Consistentemente se ha 
reportado la disminución de valores espirométricos en 
prematuros nacidos a cualquier edad gestacional, siendo 
los más afectados aquellos con enfermedad pulmonar 
crónica del prematuro o displasia broncopulmonar. Esta 
alteración se observa inclusive en aquellos nacidos entre 
las 33 y 36 semanas de edad gestacional, una población 
que generalmente no requiere de soporte respiratorio en 
el período neonatal. Existen otras formas de evaluación 
de la función pulmonar además de la espirometría, tales 
como la medición de volúmenes pulmonares, resistencia 
y reactancia de la vía aérea, hiperreactividad bron-
quial, capacidad de difusión, óxido nítrico exhalado y 
nuevas técnicas de imágenes tales como la resonancia 
magnética con gases hiperpolarizados con 3-helio. En 
esta revisión se discuten los hallazgos de estos métodos 
para evaluar el impacto del nacimiento prematuro en el 
aparato respiratorio. 
Palabras clave: Pretérmino, fisiología pulmonar, 
displasia broncopulmonar, enfermedad pulmonar 
crónica del prematuro, volúmenes pulmonares estáticos, 
imagenología, índice de aclaramiento pulmonar.
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INTRODUCTION
Preterm (defined as less than 37 weeks’ gestation) birth, 
a common occurrence, is associated with morbidity and 
mortality both in the neonatal period and beyond (1). 
Important long-term outcomes include neurodevelop-
ment and respiratory health. The latter can be assessed in 
a variety of ways from outlining symptomology to health 
care utilisation to formal lung function testing. While 
spirometry is the most common respiratory assessment in 
follow-up of preterm children, increasingly more detailed 
testing is being used for preterm-born survivors. While 
previous focus has been on the extremes of prematurity, 
in particular those who develop chronic lung disease of 
prematurity (CLD), there is increasing evidence that even 
delivery at later gestations, including early term delivery, 
is associated with lung dysfunction in childhood (2). CLD 
is often also called bronchopulmonary dysplasia (BPD) and 
the terms are often used interchangeably. This review will 
discuss the impact of risk factors on the developing lung, 
including those which lead to the development of CLD, and 
the longer term respiratory outcomes of preterm birth with 
a particular focus beyond basic spirometry, the outcomes 
of which have been a frequent subject of recent reviews 
(3, 4).
EPIDEMIOLOGY
Preterm birth accounts for approximately 11% of all live 
births worldwide, with increasing rates in many countries (5). 
It is a leading worldwide cause of death in the under 5-year 
age group (6), accounting for over 1 million deaths in 2015. 
However, neonatal mortality as a result of being born preterm 
has decreased in both the developed and developing world, 
with the overall death rate decreasing from 10.5 per 1,000 
live births 2000 to 7.6 in 2015 (7). Many of the deaths are 
due to respiratory diseases, which affect 2-3% of all newborn 
infants (8, 9); the rates of respiratory illness increase with 
decreasing gestational age. Significant progress has occurred 
in the management of preterm neonates including the use 
of maternal antenatal corticosteroid administration, exog-
eneous surfactant and gentler forms of mechanical venti-
lation (10). However, as survival improves, the longer-term 
outcomes including good quality of life for the survivors 
become increasingly important (11). 
LUNG DEVELOPMENT
An understanding of lung development is key to understand 
why preterm infants may develop future respiratory deficits 
(12, 13). Normal lung development has been classified into 
5 phases (14) (see Figure 1 (15)): 
Embryonic gestational age 0-7 weeks.
Pseudoglandular weeks 7-17.
Canalicular weeks 17-27.
Saccular weeks 28-36 and 
Alveolar weeks 36 to at least 2 years post natal age. 
In extremely preterm-born infants, especially those born 
at <26 weeks’ gestation, alveolar development has not 
yet commenced, thus the infant relies on respiratory 
saccules for their gaseous exchange. In addition, failure to 
produce adequate antioxidant, enzymes and surfactant, 
which reduces surface tension at the gas-exchanging 
units, often results in the development of neonatal respi-
ratory distress syndrome (RDS) (16). The insults of extra-
uterine life on the immature and fragile lungs occur at a 
crucial phase of lung development, resulting in subse-
quent abnormal alveolarisation and aberrant pulmonary 
vascular development (15). 
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ABBREVIATIONS:
ADC  Apparent diffusion coefficient
BPD   Bronchopulmonary dysplasia 
BHR  Bronchial hyper-responsiveness 
CLD   Chronic lung disease of prematurity
DLCO   Carbon monoxide diffusing capacity
EIB   Exercise induced bronchoconstriction
ERV  Expiratory reserve volume 
FeNO   Fractional exhaled nitric oxide
FEV0.
5/1
   Forced expired volume in 0.5/1 second(s)
FOT  Forced oscillation technique
FRC  Functional residual capacity
FVC   Forced vital capacity
Gaw  Airway conductance
IC  Inspiratory capacity
IRV  Inspiratory reserve volume
IVC  Inspiratory vital capacity
LCI  Lung clearance index
Raw  Airway resistance
Rrs  Respiratory resistance
RV  Residual volume
TLC  Total lung capacity 
VT  Tidal volume
Xrs  Respiratory reactance
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Reprinted with permission (15).
FIGURE 1. Stages of normal lung development 
RISK FACTORS FOR LONG-TERM LUNG DISEASE
Evolution of lung disease in the preterm population is a 
multi-factorial process, a combination of genetic suscepti-
bility and environmental factors. The interventions that some 
preterm infants receive are particularly important, especially 
in those who develop CLD. Reviewed below are the important 
risk factors that potentially lead to the dysfunction of the 
respiratory system.
Preterm birth
Preterm birth occurs at an earlier stage of lung development, 
thus, it is not surprising that concerns are raised regarding 
lung development after birth of preterm infants (17). Many of 
the ante- and post-natal factors that may affect lung growth 
in the preterm infant are shown in Figure 2 (14). The common 
pathway for many of these risk factors affecting lung growth 
may be via pulmonary inflammation (15) but recent data 
suggest that even late preterm-born infants (of between 33 
and 34 weeks’ gestation) or even early term-born children (at 
37 – 38 weeks’ gestation) may have longer term decrements 
of their lung function (2, 18, 19). In one study of healthy 
preterm infants who had not received any respiratory support 
during the neonatal period, increased dead space ventilation, 
lower functional residual capacity and impaired gas exchange 
at 40 weeks’ postmenstrual age were seen when compared to 
term born controls. This suggests that preterm delivery per se 
affects postnatal lung growth (20). Similar findings have been 
reported by others (21, 22). 
Chronic Lung Disease of prematurity (CLD)
CLD, often also called bronchopulmonary dysplasia (BPD), is a 
major respiratory complication of preterm birth affecting up 
to 75% of surviving infants at the extremes of gestation (<26 
weeks’ gestation) (23). Histologically, CLD was originally asso-
ciated with marked pulmonary fibrosis, varying hyperinflation 
and atelectasis, severe epithelial lesions and decreased alve-
olarisation, leading to reduced surface area for gas exchange 
(24). Since the introduction of surfactant, newer ventilation 
strategies and improved nutrition for preterm infants, the 
histology shows less fibrosis, less heterogeneity of lung disease 
and larger, fewer alveoli than observed in old BPD (17), often 
termed “new BPD/CLD”. It is likely that CLD represents the 
culmination of delivery at an immature stage of lung growth 
and exposure to factors that are well-known for causing lung 
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FIGURE 2. Ante- and post-natal risk factors that can affect lung growth directly or via pulmonary inﬂammation
injury. The risk factors for CLD have been previously reviewed 
(14, 15) but include antenatal factors such as maternal health 
(e.g. pregnancy associated hypertensive conditions), placental 
function (e.g. chorioamnionitis) (25) and fetal health (e.g. 
preterm delivery and antenatal infection) (26). Postnatal risk 
factors that may lead to lung injury include supplemental 
oxygen therapy, mechanical ventilation (especially invasive 
mechanical ventilators), respiratory infections (27), patent 
ductus arteriosus (PDA) and fluid overload. 
OTHER RISK FACTORS
Many of the risk factors discussed above are associated with 
the epidemiologically small group of extremely preterm 
infants of <28 weeks’ gestation (<1% of overall birth) espe-
cially those who require respiratory support. Many more-ma-
ture preterm-born infants of >32 weeks’ gestation will also be 
exposed to antenatal risk factors. These include intrauterine 
growth retardation (IUGR), inadequate maternal nutrition, 
maternal disease such as diabetes mellitus, pregnancy-asso-
ciated conditions such as hypertension, antenatal maternal 
smoking, postnatal smoking exposure from mothers and 
carers, and social deprivation, which could lead to future risk 
of developing lung disease. Some of these factors are known 
to be associated with preterm delivery that clearly has long-
term consequences. Placental insufficiency may prevent 
adequate lung development. In mice, chronic hypoxia during 
the stage of lung development corresponding to the human 
3rd trimester impairs alveolar and pulmonary artery devel-
opment by upregulating transforming growth factor ? (28). 
Preterm infants born with IUGR have a higher risk of devel-
oping CLD in comparison to those with appropriate birth 
weight for gestation (29). Similarly, term-born infants with 
IUGR may have long-term respiratory function deficits but 
robust studies for late preterm infants of >32 weeks’ gesta-
tion with IUGR are lacking. Interestingly, catch up growth in 
term-born infants may lead to some improvement in lung 
function (30). However, accelerated weight gain in infancy in 
both term -and preterm- born children may lead to increased 
respiratory symptoms (31) perhaps due to dysanapsis, i.e. the 
weight gain suggests somatic growth is occurring but lung 
growth may be lagging behind for a period of time with the 
mismatch resulting in respiratory symptoms. 
Association between antenatal smoking and preterm birth is 
well recognised with a recent study showing improvement in 
Reprint with permission (14).
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preterm labour rates after legislation prohibiting smoking in 
public areas was introduced in several countries (32). Nicotine 
and its metabolite cotinine cross the placenta and are found in 
higher concentrations in the foetal serum, amniotic fluid and 
placenta than in maternal serum (33). Animal models have shown 
the specific effects of maternal smoking on fetal lung growth 
and development including smaller lung volumes and structural 
changes, including fewer but larger saccules, decreased elastic 
tissue length and decreased internal surface area in foetal rat 
lungs (34). Antenatal maternal smoking can impact on lung 
function in infancy, with those exposed having 7% lower FEV0.5 
(forced expiratory volume in 0.5 seconds) (35) and reduced time 
to peak tidal expiratory flow (36, 37). Preterm-born infants with 
an average gestational age of 33 weeks at birth, exposed to ante-
natal maternal smoking and assessed prior to hospital discharge, 
had reductions in expiratory flow parameters, in particular a 13% 
slower time to peak tidal expiratory flow as a proportion of total 
expiratory time, compared to those not exposed (38). In addi-
tion, a relationship between antenatal smoking and wheeze has 
been noted, including in infancy (39), childhood (40), and with 
evidence suggesting that this persists into adulthood (41). 
Socioeconomic class is associated with preterm birth. In an 
epidemiological study of over 800,000 births between 1994 
and 2004 in Australia, preterm birth was linked to lower socio-
economic status. Birth at decreasing gestational age was linked 
to increasing deprivation, with an odds ratio of 1.45 for being 
born extremely preterm for those in the lowest quartile of 
socioeconomic disadvantage when compared to the highest 
quartile (42). Additionally, lung dysfunction has been linked 
to lower socioeconomic status, with reductions of FEV1 (forced 
expiratory volume in 1 second) and FVC (forced vital capacity) 
by ~17% in boys and ~14% in girls of children from low-income 
groups in comparison to high income groups (43).
IMPACT OF PRETERM BIRTH ON RESPIRATORY 
HEALTH
Symptoms and health care utilisation
Preterm birth and the associated complications have a signif-
icant impact on future respiratory health. For instance, during 
infancy, those born preterm are at higher risk of respiratory 
diseases. A population-based study of over 300,000 children 
noted that decreasing gestational age was associated with 
increasing respiratory morbidity. Almost a quarter of all infants 
born at <33 weeks’ gestation required an admission for respi-
ratory illness before the age of 1 year compared to 7.8% of 
those born at 40-42 weeks’ gestation, with a fourfold increase 
in actual number of admissions (41.5 vs 9.8 per 100 child-
years respectively). With every week of decreasing gestation 
from 40 to 33 weeks, there was an increase in both proportion 
of infants admitted and number of admissions. Even those born 
late preterm at 35-36 weeks’ gestation had almost double the 
proportion requiring admission and number of admissions 
(13.5% and 18.8 admissions per 100 child-years respectively) 
compared to the 40-42 weeks’ gestation group. Additionally, 
the lower the gestation of the infant, the earlier in life they 
were likely to be admitted. This finding was not confined to 
the infant population, with the 1-5 years age group showing a 
similar but less marked trend (44).
Respiratory symptoms in preterm-born children are not 
restricted to those born at extremes of prematurity. A ques-
tionnaire-based study of preterm- and term-born children 
from Wales received over 7000 replies, with respondents 
classified into preschool aged (<5 years) and school aged (≥5 
years) children. In the younger age group, those born very 
preterm (≤32 weeks’ gestation) were 2.8 times more likely to 
have wheeze-ever compared to the term controls. Further-
more, those born moderately (33-34 weeks’ gestation) and 
late (35-36 weeks’ gestation) preterm also had greater rates 
of wheeze-ever (odds ratios of 1.9 and 1.5) when compared 
to the term group. Similarly, the school aged children also 
had greater odds ratios for wheeze-ever (respectively 3.29, 
1.84, and 1.58 for the <32, 33–34 and 35–36 weeks’ gesta-
tion groups) when compared to term controls. Similar trends 
were seen for both age groups for recent wheeze, recent 
hospital admissions for respiratory illness and inhaled medi-
cation use (45). Even children born at early term (37-38 
weeks’ gestation) from both age groups had increased respi-
ratory symptoms and medication use than later term-born 
subjects (39-42 weeks’ gestation) (18), a finding recently 
confirmed with spirometry (19). Similar findings were 
reported in another study of over 14000 UK born children 
by face-to-face interviews showing an increasing gradient of 
respiratory symptoms with decreasing gestational age (46). 
A systematic review of 30 studies including over 1.5 million 
children showed that those born preterm were 1.7 times 
more likely to be affected by wheeze, in particular those 
born at <32 weeks’ gestation who were 3 times more likely 
to have wheezing disorders (47).
CLD in particular is associated with poorer respiratory 
outcomes. In the follow-up of the UK EPICure population 
of extreme preterms born in 1995 at <26 weeks’ gestation, 
an association was noted between CLD and prevalence of 
respiratory symptoms and medication use when compared 
to term-born controls. Rate of treatment with either bron-
chodilator therapy or inhaled steroids during the first year of 
life was approximately 20% higher in those with a history of 
CLD compared to those without. By 6 years of age, signifi-
cantly more children with a history of CLD had suffered from 
wheeze in the previous year, wheeze or cough at night, or 
had received bronchodilators or inhaled steroids within the 
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past 12 months when compared to term controls (48). At 
11 years of age, the preterm group had 9-14% higher rates 
of an asthma diagnosis, requiring asthma medication, or 
having suffered from nocturnal cough or exercise-induced 
wheeze within the past 12 months than term-born children. 
Those with a history of CLD had a 13% higher rate of wheeze 
within the past 12 months (49).
Respiratory disease following preterm birth can persist into 
adulthood. Follow-up of a cohort of preterm-born adults at 
age 21 revealed higher rates (over a quarter of the subjects) 
of cough, wheeze or asthma compared to term controls (50). 
Other studies have reported higher rates of ongoing respi-
ratory symptoms in populations of preterm-born adults with 
a history of CLD. Wong et al revealed respiratory symptoms 
were experienced by 71% of their study population of 17-33 
year olds within the past 12 months (51).
Impact of preterm birth on lung function testing
In addition to subject-reported respiratory symptoms, 
objective data on the impact of preterm birth on the respi-
ratory system can be obtained from lung function testing. 
Spirometry can reveal obstructive and restrictive lung 
abnormalities and is widely available with equipment that 
can be reliably used within community settings as well as in 
specialist lung physiology labs (52). However, there are also 
many other respiratory investigations that have been used 
to understand lung dysfunction following preterm birth.
Spirometry
Abnormalities on spirometry testing have been consis-
tently noted in preterm populations during childhood, with 
the highest levels of dysfunction observed in those with a 
previous history of CLD. Synthesised data from a meta-anal-
ysis show that preterm infants, excluding those with a history 
of CLD, have a deficit of 7% of percent predicted  FEV1  when 
compared to term controls. Populations with a previous 
diagnosis of CLD of supplemental oxygen dependency at 
either 28 days of age or beyond 36 weeks’ post-menstrual 
age have deficits of 16% and 19% respectively (53). In addi-
tion to respiratory symptoms, lung function abnormalities 
are not confined to those born very or extremely preterm. 
Those born at 33-34 weeks’ gestation also have spirometry 
deficits during mid-childhood, of between 0.35 and 0.49 
for adjusted mean z-scores for  FEV1 , FVC, and expiratory 
flow rates when compared to term-born children. Similar 
deficits were seen in children born at earlier gestations (2). 
Since lung function is thought to “track” throughout life, of 
particular concern is the premature development of chronic 
obstructive pulmonary disease in children, especially if 
preterm-born children are exposed to additional insults 
such as environmental pollution (54).
As well as having baseline spirometry deficits, preterm-
born children, especially those who had CLD, appear to have 
increased bronchial hyper-responsiveness (BHR) in some 
studies (55). BHR may persist in adulthood, with increased 
response to methacholine shown in one population of 
extremely preterm-born adults (56) and across all preterm 
groups in comparison to term controls in another (57). 
However, not all studies have shown increased prevalence 
of BHR in preterm-born children (58). Exercise-induced 
bronchoconstriction (EIB) is also seen in preterm popula-
tions, particularly CLD groups, as shown by Joshi et al, with a 
maximal average FEV1 decrease of 11% at approximately 20 
minutes post-exercise (59).
Static lung volumes
Although spirometry is the most common method for 
assessing lung function, it has limitations in the paediatric 
population. Measuring dynamic lung volumes requires 
cooperation and coordination on the part of the partici-
pant performing the procedure. It may, therefore, be diffi-
cult to obtain accurate results, especially in younger age 
groups (60). Body plethysmography allows measurement of 
static lung volumes, providing structural information about 
the lungs. These include total lung capacity (TLC), func-
tional residual capacity (FRC), residual volume (RV) and vital 
capacity (VC). These lung volumes can be represented sche-
matically as seen in Figure 3 (61).
This method is useful to identify lung hyperinflation from 
increased RV or FRC. Additionally, increased RV/TLC ratio can 
also suggest hyperinflation, although this finding is less specific 
as it may result from normal RV but decreased TLC (62). Hyper-
inflation is associated with obstructive lung disease or struc-
FIGURE 3. A schematic representation of subdivisions of 
lung volume
IRV: inspiratory reserve volume; VT: tidal volume; ERV: expiratory reserve 
volume; IVC: inspiratory vital capacity; RV: residual volume; IC: inspira-
tory capacity, FRC: functional residual capacity; TLC total lung capacity. 
Reprinted with permission (61).
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tural abnormalities associated with preterm birth (63). Static 
lung volumes have been investigated in a number of studies 
of preterm-born children and young adults. In general, RV 
and RV/TLC are increased in preterm-born subjects with the 
greatest increases seen in those with CLD when compared 
to term-born equivalent controls (59, 64-69). These find-
ings suggest that the injuries occurring in infancy persist and, 
despite remodelling, there is continuing evidence of air-trap-
ping likely to be related to the airway obstruction consistently 
observed in preterm-born children. A possible association 
between hyperinflation and bronchial hyper-reactivity (70) 
suggests the mechanism of air-trapping may be that of a ball-
valve, with air being able to enter the lungs but, due to either 
floppy or constrictive airways, unable to escape. Whether 
these improve or deteriorate with ageing will be important to 
assess in longitudinal studies as well as whether they have any 
response to, or indeed worsening after, bronchodilator treat-
ment which has not yet been accurately assessed. 
Airway resistance and respiratory mechanics
Respiratory mechanics, which include measurements of airway 
resistance and compliance, can give valuable insight into the 
underlying disease processes. Airway resistance in particular 
can be measured using different techniques including body 
plethysmography and forced oscillation technique (FOT). 
A number of studies have used body plethysmography to 
compare respiratory mechanics in preterm groups against term 
controls. Increased Raw or decreased airway conductance (Gaw, 
reciprocal of Raw) are commonly reported in preterm groups 
(69, 71, 72). In addition, among preterm-born children with a 
history of CLD, Raw is increased (1.05 kPa·L·s-1) compared to 
preterm controls without CLD (0.75 kPa·L·s-1) (73).
FOT involves assessing the respiratory response to soundwaves 
superimposed on tidal breathing at varying frequencies. The 
lower frequency waves travel further into the lungs to give infor-
mation about the distal airways whereas the higher frequencies 
report on the proximal airways. Both of these procedures have 
advantages for the paediatric population as they rely on tidal 
breathing (74, 75). Correlation has been noted between airway 
resistance (Raw) obtained by plethysmography and resistance 
measured at 5 Hz during FOT measurements (73). Reactance 
at 5 Hz has been shown to correlate with spirometry (73, 76), 
suggesting that FOT may be a useful alternative for assessing 
lung disease in young children born preterm.
The study by Malmberg et al of preterm-born children (aged 
8 years and born at <30 weeks’ gestation) had significantly 
higher resistance and lower reactance (Xrs), at the lower 
frequencies (5 and 10 Hz) compared to their term counter-
parts. The findings suggest that smaller, distal airways are 
predominantly affected. This may be due to altered elastic 
properties of the lungs resulting from airway obstruction 
associated with preterm birth (73). A subgroup of 16 children 
from this study underwent pre- and post-bronchodilator 
measurements of Rrs at 5 Hz (peripheral airways). The preterm 
children had a 10% greater decrease in resistance values 
following bronchodilator administration compared to the 
term control group, suggesting a greater degree of reversible 
airways disease as a result of an obstructive picture (77).
In another study, Vrijlandt et al compared preterm-born children 
aged 3–5 years with and without CLD with term controls. Both the 
preterm groups had similar resistance values at 6 Hz which were 
significantly higher compared to controls; lower reactance values 
at 6 Hz were noted in the CLD group compared to the non-CLD 
preterm group. The resonant frequency, the frequency at which 
the lower frequency elastic properties and the higher frequency 
inertial properties cancel each other out, was also highest in the 
CLD group (26.8 Hz) compared to the other groups (22.7 Hz) (78). 
Udomittipong and colleagues obtained similar findings assessing 
64 children aged 3–6 years and diagnosed with CLD. Resistance 
and reactance values at 6, 8 and 10 Hz were measured and 
compared to a previous healthy control cohort. The z-scores were 
increased for resistance (between 1.03 and 1.28) and decreased 
for reactance (between -1 and -1.41) when compared to the 
control group (79). Bronchodilators improved both Rrs and Xrs at 
6, 8 and 10 Hz, with decreases of between 18.2 and 23.3% from 
baseline values for the former and increases of between 31.9 
and 38.8% for the latter (80). More recent studies (76, 81) also 
report increased resistance and decreased reactance particularly 
in those with a history of (severe) CLD.
Interestingly, Er et al reported increased resistance values at 5 
and 10 Hz in late preterm children aged 3–7 years with gesta-
tion at birth of 34-36 weeks when compared to term-born 
controls, further suggesting that peripheral airway disease 
may be a consequent of delivery at an early stage of lung 
development (82).
Overall findings from FOT consistently show increased resis-
tance and decreased reactance, particularly at lower frequen-
cies, in preterm-born children with the worst values observed 
in those with a history of CLD. The observations are most likely 
to be due to altered structure resulting after birth at an early 
stage of lung development.
Diffusing capacity
Carbon monoxide diffusing capacity (DLCO) of the lungs is 
a well-described technique whereby the ability of oxygen 
to transfer from the alveoli into the lungs’ capillary network 
is assessed using carbon monoxide thus giving information 
about the alveolar-capillary interface. There are a number of 
methods to measure DLCO but the single breath technique 
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is most commonly used. It is determined from concurrent 
measurements of carbon monoxide uptake from alveolar gas 
and the volume of the alveoli. There are several factors that 
can affect this uptake, including structural abnormalities (e.g. 
lung volumes, area of capillary-alveolar interface) and functional 
issues (e.g. ventilation-perfusion mismatch, gas tensions within 
the blood) (83). In several studies, preterm-born children with 
CLD had similar DLCO values to preterm control groups (68, 
84). A more recent study of 126 preterm children and 34 term 
born children showed DLCO was lower in controls (86.3 percent 
predicted) than in preterm subjects (92.1 percent predicted) 
suggesting that preterm-born children are unlikely to have any 
significant gas exchange abnormalities (69). 
In contrast, Hakulinen et al assessed 31 preterm-born children 
with and without CLD compared to healthy term controls. The 
preterm groups had significantly lower percent predicted DLCO 
compared to the term group (91.1% and 89.5% in the preterm 
groups, and 100.7% in the controls, p=0.021) (71). Data from 
a Finnish cohort showed similar results in their cohort of 55 
preterm-born, very low birth weight (<1500g) children, both 
with and without CLD. Both these groups had significantly 
lower DLCO, including when corrected for alveolar volume, 
with percent predicted values of 91% and 94% in the CLD and 
no-CLD preterm groups respectively, compared to 102% in the 
term control group (72). Cazzato and colleagues noted that 
DLCO in a group of very low birth weight (≤1500g), very preterm 
(≤32 weeks’ gestation) children was approximately 1 z-score 
lower when compared to term controls (85). A similar deficit in 
z-score was noted in the EPICure cohort of extreme preterm 
children when compared to term controls (66).
In other studies, subjects with a history of CLD have been 
shown to have decreased diffusion capacity. Balinotti et al 
studied infants with CLD aged between 4 and 18 months 
after birth at 24-29 weeks’ gestation, reporting lower DLCO 
of 2.7 versus 3.4ml/min/mmHg adjusted for lung volume in 
the CLD group compared to term controls (86). For Joshi et 
al, a CLD group in mid-childhood had lower predicted DLCO 
values compared to a preterm-born group without CLD 
(74.6% versus 89.7%) (59).
In general, there appears to be observations of impaired alve-
olar-capillary interface after preterm birth especially in those 
who develop CLD, although not all studies report differences.
Exhaled nitric oxide testing
Fractional exhaled nitric oxide (FeNO) has been used as a 
marker of (eosinophilic) inflammation in respiratory diseases. 
While higher concentrations have been reported in asthma 
(87), a label often inappropiately given to preterm-born 
children with airway obstruction, there is little evidence of 
increased FeNO in preterm-born children including those who 
had CLD in infancy. In infancy, nitric oxide output (exhaled 
NO accounting for expiratory flow) appears to be lower in CLD 
populations compared to healthy preterm- and term-born 
children (after adjusting for sex, atopy, passive smoke exposure 
and caffeine consumption) with 10% and 17% lower values 
respectively (88). Lower concentrations of exhaled nitric oxide 
were noted in 31 preterm-born school-aged children with a 
diagnosis of CLD in comparison to healthy preterm and term 
controls (7.7, 9.9 and 10.7 parts per billion (ppb) respectively) 
(89). Results remain similar in adulthood, with median FeNO 
of 19 ppb in preterm-born children with and without CLD and 
27 ppb in term-born controls (p=ns) (90). The data suggest 
that there is unlikely to be eosinophilic inflammation occur-
ring in preterm-born children with airway obstruction. 
Lung clearance index
The lung clearance index (LCI), using multiple breath washout 
techniques, assesses ventilation inhomogeneity. In disorders 
such as cystic fibrosis, LCI is useful in detecting early lung disease 
(91). Given the continuing airway and parenchymal abnormalities 
observed in preterm survivors, especially those with a history of 
CLD, LCI may be useful in assessing ventilation inhomogeneity. 
Surprisingly, in general, studies have not consistently reported 
differences between preterm-born children with or without 
CLD and term-born children (92-95). Lum et al noted increased 
LCI which may be due to decreased gas mixing efficiency in the 
extremely preterm group of <26 weeks’ gestation which may 
reflect some parenchymal or small airway disease, but the LCI 
was not helpful in discriminating lung disease between preterm 
groups with and without CLD and term groups. Hülskamp and 
colleagues did not find differences for LCI between preterm and 
term groups but on multivariable analyses noted an association 
between ventilation inhomogeneity and duration of supple-
mental oxygen. It has been speculated that the lack of differen-
tiation using LCI in children with established airway disease and 
changes on imaging such as CT scans (see below) may be due 
to fixed airway obstruction beyond which the study gas may not 
diffuse during testing, hence lack of inhomogeneity observed. 
Lung imaging
Preterm-born children, including those who had CLD in infancy, 
do not routinely undergo imaging with chest radiographs 
or CT scans unless there is an underlying clinical indication. 
Where they have been reported, chest radiographs show areas 
of collapse and hyperinflation in keeping with the reported 
air-trapping seen in preterm-born children with significant 
airway disease. The few studies reporting data on thoracic CT 
scans are, in general, of subjects from the pre-surfactant era 
with abnormalities such as opacification, bronchial and inter-
lobal septa thickening, and air trapping, especially in those who 
had CLD in infancy (96-98). In the study by Wong et al, 84% of 
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subjects with CLD showed evidence of emphysema, as demon-
strated in Figure 4 (51). More recently, hyperpolarised 3-helium 
MRI scanning has been used to assess alveolar dimensions using 
the apparent diffusion coefficient (ADC). One initial study shows 
that the ADC was remarkably similar in preterm-born chil-
dren with and without CLD and term-born controls (99), thus 
suggesting that there is alveolar development occurring well 
beyond the currently accepted two years of age.
FIGURE 4. CT thorax of a 20 year old with a history of 
BPD
The arrows indicate emphysematous changes in the left lung ﬁeld, while 
the arrowhead shows a large right upper lohe bulla. Reprinted with 
permission (51).
CONCLUSION
Lung dysfunction is associated with preterm birth and there 
are increasing concerns the deficits may progress to chronic 
lung disease in adulthood. The causes of the lung deficits asso-
ciated with preterm birth are multifactorial but are largely due 
to the interruption of the normal in-utero lung growth and 
development, which can be subsequently compounded by 
(pulmonary) inflammatory processes triggered either in-utero 
(e.g. by chorioamnionitis) and/or by postnatal interventions 
such as mechanical ventilation and oxygen therapy. While 
previous emphasis has been on the respiratory outcomes of 
those born at the more extremes of preterm, in particular 
those with CLD, it is clear that even those born moderately 
preterm are at risk of future decrements of their respiratory 
function. There are a variety of investigative options to aid 
diagnosis of lung dysfunction, increase our understanding of 
the underlying mechanisms and to assess responses to treat-
ment, which are currently lacking for preterm-born children 
(100). Several techniques offer promise of increasing knowl-
edge of disease mechanisms, for instance, FOT that can be 
used in the younger, preschool-aged children where alter-
native modes of testing have difficulties. There is also the 
potential to assess if quality of life, including physical activity 
in preterm-born children (101, 102), improves after treat-
ment of the deficits in lung function observed in preterm-
born children.
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